axitinib,nivolumab,ipilimumab
pfizer,bms
['renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'pfizer']
at asco #gu23, see a study examining the impact of number treatment lines on overall survival in patients with metastatic #renalcellcarcinoma following 1l immunotherapy-based combination regimen 673 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ